Motor Function Tests – Grip Strength Test

The Grip Strength test is a straightforward and widely used behavioral assay that measures muscle strength and neuromuscular function in rodents

Key Research Model Applications of the Grip Strength Test

The Grip Strength test measures the maximum force a rodent can exert when pulling on a specialized grip bar. During the Grip Strength test, the neuromuscular function of a mouse is assessed by measuring the peak force a mouse applies by grasping a bar connected to a force meter. A rodent (mouse or rat) instinctively grasps the bar, and the force required to detach the animal from the grip is recorded as a measure of its muscle strength. Five trials with front paws are followed by five trials with both the front and hind paws combined. Accordingly, the median of these five trials is used as a measure of grip strength. Therefore, the results provide clear, quantitative data on grip force, which is a direct indicator of neuromuscular integrity.

This test is a fast, simple, and highly reproducible method for evaluating muscle strength and neuromuscular function in rodents. It provides critical, quantitative data that are essential for studying muscular weakness, motor function impairments, and therapeutic efficacy in preclinical models. As part of InnoSer’s innovative preclinical neurology CRO solutions, this motor function test is commonly used in combination with several other motor tests, such as Balance Beam test, Rotatod, or CatWalk automated gait analysis system. However, as each motor function test is unique, targeting different motor function skills in rodents, we recommend you discuss the most appropriate motor function behavioral test battery with our neurology study directors.

Preclinical behavioral test for drug development

Mouse Behavioral Testing Made Simple.

Explore our extensive portfolio of validated and tailored behavioral and cognitive rodent tests designed to advance your research.

Balance Beam Test Sample Data

The People Behind Your Research

Thomas Vogels, PhD Neurology study director InnoSer

Thomas Vogels, PhD, In Vivo Neurology Study Director

Leads an expert team of scientists with vast experience in our Neurology models to help you choose the right model and guide your optimal study design. We provide the solution to accelerating your drug development.

AAALAC Accreditation

InnoSer has earned the AAALAC accreditation, demonstrating our commitment to responsible animal care and use. AAALAC International is a nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. Our accreditation is valid for three years, incl. 2023. Read more about the AAALAC accreditation programme here.

AAALAC logo

Animal Welfare

The 3Rs impact everything from policy and regulatory change to the development and uptake of new technologies and approaches. This is why InnoSer has ongoing commitment and monitoring of these processes. The steps we practice maximize our ability to replace, reduce and refine animal involvement and facilitate our commitment to these principles when it comes to research and drug development.

Stay Curious: More Articles to Explore

MDX Mouse Model Validation Data

MDX Mouse Model Validation Data

This month we’re highlighting one of the most commonly used mouse models to study Duchenne Muscular Dystrophy (DMD) – the MDX mouse model B10.mdx), and explore how our advanced services can support your efficacy studies in DMD.   The X-linked muscular dystrophy (MDX)...

Phenotyping of a C3-PMP22 mouse model of CMT1A 

Phenotyping of a C3-PMP22 mouse model of CMT1A 

Charcot-Marie Tooth (CMT) disease is a hereditary, demyelinating peripheral neuropathy, leading to progressive muscle atrophy, weakness and subsequent walking disabilities and sensory impairments. Charcot-Marie Tooth Type 1A (CMT1A) is the most common type of CMT,...